HIV late presenters are at high risk of Cytomegalovirus reactivation and end-organ disease. CMV viremia has been associated with poor survival but the effect of anti-CMV treatment has not been studied in this setting.
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment
Calcagno, Andrea;
2018-01-01
Abstract
HIV late presenters are at high risk of Cytomegalovirus reactivation and end-organ disease. CMV viremia has been associated with poor survival but the effect of anti-CMV treatment has not been studied in this setting.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
